Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6208 USD | -1.85% | -3.15% | -16.74% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.74% | 13.34M | |
+69.09% | 62.86B | |
-0.85% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.63% | 26.46B | |
-22.15% | 18.9B | |
+4.63% | 12.67B | |
+24.53% | 12.27B | |
+28.21% | 12.07B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Onconova Therapeutics : Noble Capital Upgrades Onconova Therapeutics to Outperform From Market Perform, Adjusts Price Target to $0.46 From $0.30